148 related articles for article (PubMed ID: 21721458)
21. Embolic implications of combined risk factors in patients with patent foramen ovale (the CARPE criteria): consideration for primary prevention closure?
Rigatelli G; Dell'Avvocata F; Giordan M; Braggion G; Aggio S; Chinaglia M; Roncon L; Cardaioli P; Chen JP
J Interv Cardiol; 2009 Aug; 22(4):398-403. PubMed ID: 19515082
[TBL] [Abstract][Full Text] [Related]
22. Primary transcatheter patent foramen ovale closure is effective in improving migraine in patients with high-risk anatomic and functional characteristics for paradoxical embolism.
Rigatelli G; Dell'Avvocata F; Ronco F; Cardaioli P; Giordan M; Braggion G; Aggio S; Chinaglia M; Rigatelli G; Chen JP
JACC Cardiovasc Interv; 2010 Mar; 3(3):282-7. PubMed ID: 20298985
[TBL] [Abstract][Full Text] [Related]
23. Patent foramen ovale and unexplained ischemic cerebrovascular events in children.
Benedik MP; Zaletel M; Meglic NP; Podnar T
Catheter Cardiovasc Interv; 2007 Dec; 70(7):999-1007. PubMed ID: 18044736
[TBL] [Abstract][Full Text] [Related]
24. Transseptal puncture to facilitate device closure of "long-tunnel" patent foramen ovale.
Thompson AJ; Hagler DJ; Taggart NW
Catheter Cardiovasc Interv; 2015 May; 85(6):1053-7. PubMed ID: 25380406
[TBL] [Abstract][Full Text] [Related]
25. Transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Procedural and follow-up results after implantation of the Starflex occluder device with conjunctive intensified anticoagulation regimen.
Fischer D; Fuchs M; Schaefer A; Schieffer B; Jategaonkar S; Hornig B; Drexler H; Meyer GP
J Interv Cardiol; 2008 Apr; 21(2):183-9. PubMed ID: 18312307
[TBL] [Abstract][Full Text] [Related]
26. Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis.
Stortecky S; da Costa BR; Mattle HP; Carroll J; Hornung M; Sievert H; Trelle S; Windecker S; Meier B; Jüni P
Eur Heart J; 2015 Jan; 36(2):120-8. PubMed ID: 25112661
[TBL] [Abstract][Full Text] [Related]
27. Residual shunt after percutaneous closure of patent foramen ovale with AMPLATZER occluder devices - influence of anatomic features: a transcranial Doppler and intracardiac echocardiography study.
Marchese N; Pacilli MA; Inchingolo V; Fanelli R; Loperfido F; Vigna C
EuroIntervention; 2013 Jul; 9(3):382-8. PubMed ID: 23872652
[TBL] [Abstract][Full Text] [Related]
28. Late results after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism using the amplatzer PFO occluder without intraprocedural echocardiography: effect of device size.
Wahl A; Tai T; Praz F; Schwerzmann M; Seiler C; Nedeltchev K; Windecker S; Mattle HP; Meier B
JACC Cardiovasc Interv; 2009 Feb; 2(2):116-23. PubMed ID: 19463412
[TBL] [Abstract][Full Text] [Related]
29. The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale.
Aral M; Mullen M
Catheter Cardiovasc Interv; 2015 May; 85(6):1058-65. PubMed ID: 25413379
[TBL] [Abstract][Full Text] [Related]
30. Factors related to recurrence of paradoxical cerebral embolism due to patent foramen ovale.
Fukuoka T; Dembo T; Nagoya H; Kato Y; Yasuko O; Deguchi I; Maruyama H; Horiuchi Y; Takeda H; Tanahashi N
J Neurol; 2012 Jun; 259(6):1051-5. PubMed ID: 22057407
[TBL] [Abstract][Full Text] [Related]
31. Paradoxical emboli--clinical importance of transcranial Doppler for detection of patent foramen ovale.
Zivanović Z; Ruzicka-Kaloci S; Jesić A; Radovanović B; Lucić-Prokin A; Slankamenac P
Med Pregl; 2010; 63(7-8):445-9. PubMed ID: 21443152
[TBL] [Abstract][Full Text] [Related]
32. Cryptogenic stroke and patent foramen ovale: clinical clues to paradoxical embolism.
Ozdemir AO; Tamayo A; Munoz C; Dias B; Spence JD
J Neurol Sci; 2008 Dec; 275(1-2):121-7. PubMed ID: 18822432
[TBL] [Abstract][Full Text] [Related]
33. PFO and stroke: what are the data?
Wechsler LR
Cardiol Rev; 2008; 16(1):53-7. PubMed ID: 18091402
[TBL] [Abstract][Full Text] [Related]
34. Recurrent events following patent foramen ovale closure in patients above 55 years of age with presumed paradoxical embolism.
Spies C; Khandelwal A; Timmemanns I; Kavinsky CJ; Schräder R; Hijazi ZM
Catheter Cardiovasc Interv; 2008 Dec; 72(7):966-70. PubMed ID: 18942060
[TBL] [Abstract][Full Text] [Related]
35. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study.
Homma S; Sacco RL; Di Tullio MR; Sciacca RR; Mohr JP;
Circulation; 2002 Jun; 105(22):2625-31. PubMed ID: 12045168
[TBL] [Abstract][Full Text] [Related]
36. Implantation of a Occlutech Figulla PFO occluder in a patient with patent foramen ovale and history of embolic stroke.
Krecki R; Peruga JZ; Plewka M; Krzemińska-Pakuła M; Kasprzak JD
Cardiol J; 2008; 15(4):380-2. PubMed ID: 18698549
[TBL] [Abstract][Full Text] [Related]
37. Transcatheter patent foramen ovale closure is effective in reducing migraine independently from specific interatrial septum anatomy and closure devices design.
Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Braggion G; Chinaglia M; Roncon L
Cardiovasc Revasc Med; 2010; 11(1):29-33. PubMed ID: 20129358
[TBL] [Abstract][Full Text] [Related]
38. Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud® in patients with stroke or transient ischemic attack.
Steinberg DH; Bertog SC; Momberger J; Franke J; Hofmann I; Renkhoff K; Joy S; Vaskelyte L; Sievert H
Catheter Cardiovasc Interv; 2015 Jun; 85(7):1262-7. PubMed ID: 24948394
[TBL] [Abstract][Full Text] [Related]
39. Paradoxical embolization of brachiocephalic and pulmonary arteries in a case of persistent foramen ovale: a case report.
Irqsusi M; Waldhans S; Vannucchi A; Vogt S; Karatolius K; Noutsias M; Zoremba M; Bien S; Moosdorf R
Thorac Cardiovasc Surg; 2011 Aug; 59(5):308-10. PubMed ID: 21476191
[TBL] [Abstract][Full Text] [Related]
40. Recurrent events after percutaneous closure of patent foramen ovale.
Wallenborn J; Bertog SC; Franke J; Steinberg DH; Majunke N; Wilson N; Wunderlich N; Sievert H
Catheter Cardiovasc Interv; 2013 Oct; 82(4):541-6. PubMed ID: 22707325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
